NorthWest Biotherapeutics Inc (NWBO)

[Ready4bluesky]

So you are contending they obviously (nice authoritative statement from a position of ignorance BTW) changed the enrollment criteria during the phase 1 which essentially confounds the difference in efficacy between the activation methods.

However, in post #35462 you state, "with all the interest in the phase 1 DcVax-Direct trial, it would not be difficult for the NWBO sponsored study researchers to find and enroll select patients with the highest life expectancy and slowest progressing tumors they could find."

In post #35242 you write, "being stage IV does not automatically mean the cancer is swiftly progressing, and from MDA they had hundreds to select from."

So, with all of these patients to choose from, why in the world would they select anyone close to the 3 month minimum expectancy requirement? You are asserting that NWBO is cherry picking patients under the 6 mo. expectancy requirement, but didn't do so under the even lower 3 month minimum? Your argument has so many holes in it. Even a hack like me can quickly see that.